Reference
NICE. Life-extending lung cancer drug will be more widely available on the NHS after NICE review. Internet Document : 6 Jun 2018. Available from: URL: https://www.nice.org.uk/news/article/life-extending-lung-cancer-drug-will-be-more-widely-available-on-the-nhs-after-nice-review
Rights and permissions
About this article
Cite this article
NICE: pembrolizumab to be more widely available for lung cancer. PharmacoEcon Outcomes News 805, 39 (2018). https://doi.org/10.1007/s40274-018-5041-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5041-9